Abstract
Aims
Necrotizing soft-tissue infections (NSTI) are rare but severe diseases with rapid progression. Rates of mortality and morbidity are high and early diagnosis, immediate surgical intervention and antibiotic treatment are essential to improve prognosis. Thus, our commentary emphasizes important information in the management of NSTI.
Methods
We describe the essentials in the management of necrotizing soft-tissue infections.
Results
Six essentials were identified:
-
1.
Necrotizing soft-tissue infections (NSTI) are primarily diagnosed clinically; pain out of proportion, rapid progression of skin infection and systemic signs should alert clinicians.
-
2.
Early diagnosis can be rather delayed by several factors such as absence of fever, significant cutaneous manifestations, elevation of inflammatory parameters, systemic signs, and non-specific imaging tests.
-
3.
NSTI can occur both in the elderly or patients with underlying diseases after major trauma (usually polymicrobial Gram-negative and Gram-positive pathogens) but also in healthy patients after minor trauma (often monomicrobial; most common among Gram-positive organisms: group A Streptococcus).
-
4.
Immediate and radical debridement (incl. re-debridement after 24 h) remains the cornerstone of surgical therapy.
-
5.
Empirical broad-spectrum antimicrobial treatment has to be administered shortly after admission. After isolation of the causative bacteria therapy should be tailored.
-
6.
The value of adjunctive measures (hyperbaric oxygen therapy, intravenous immunoglobulines) is uncertain and their routine use cannot be recommended.
Summary
Further efforts should be undertaken to increase the awareness for and the adherence to the essentials in the management of necrotizing soft-tissue infections.
References
May AK, Stafford RE, Bulger EM, Heffernan D, Guillamondegui O, Bochicchio G, et al. Treatment of complicated skin and soft tissue infections. Surg Infect. 2009;10:467–99. https://doi.org/10.1089/sur.2009.012.
Pham TN, Moore ML, Costa BA, Cuschieri J, Klein MB. Assessment of functional limitation after necrotizing soft tissue infection. J Burn Care Res. 2009;30:301–6. https://doi.org/10.1097/BCR.0b013e318198a241.
Wang YS, Wong CH, Tay YK. Staging of necrotizing fasciitis based on the evolving cutaneous features. Int J Dermatol. 2007;46:1036–41. https://doi.org/10.1111/j.1365-4632.2007.03201.x.
Goh T, Goh LG, Ang CH, Wong CH. Early diagnosis of necrotizing fasciitis. Br J Surg. 2014;101:e119–25. https://doi.org/10.1002/bjs.9371.
Alayed KA, Tan C, Daneman N. Red flags for necrotizing fasciitis: a case–control study. Int J Infect Dis. 2015;36:15–20. https://doi.org/10.1016/j.ijid.2015.04.021.
Stevens DL, Bryant AE. Necrotizing soft-tissue infections. N Engl J Med. 2017;377:2253–65. https://doi.org/10.1056/NEJMra1600673.
Tso DK, Singh AK. Necrotizing fasciitis of the lower extremity: imaging pearls and pitfalls. Br J Radiol. 2018. https://doi.org/10.1259/bjr.20180093.
Wong CH, Khin LW, Heng KS, Tan KC, Low CO. The LRINEC (Laboratory Risk Indicator for Necrotizing Fasciitis) score: a tool for distinguishing necrotizing fasciitis from other soft tissue infections. Crit Care Med. 2004;32:1535–41.
Sartelli M, Malangoni MA, May AK, Viale P, Kao LS, Catena F, et al. World Society of Emergency Surgery (WSES) guidelines for management of skin and soft tissue infections. World J Emerg Surg WJES. 2014;9:57. https://doi.org/10.1186/1749-7922-9-57.
Schulin T. Bacterial etiology of soft tissue infections. Infection. 2018;46:577. https://doi.org/10.1007/s15010-018-1145-1.
Chao WN, Tsai CF, Chang HR, Chan KS, Su CH, Lee YT, et al. Impact of timing of surgery on outcome of Vibrio vulnificus-related necrotizing fasciitis. Am J Surg. 2013;206:32–9. https://doi.org/10.1016/j.amjsurg.2012.08.008.
Eckmann C. The importance of source control in the management of severe skin and soft tissue infections. Curr Opin Infect Dis. 2016;29:139–44. https://doi.org/10.1097/QCO.0000000000000240.
Stevens DL, Bisno AL, Chambers HF, Dellinger EP, Goldstein EJ, Gorbach SL, et al. Practice guidelines for the diagnosis and management of skin and soft tissue infections: 2014 update by the Infectious Diseases Society of America. Clin Infect Dis. 2014;59:e10–52. https://doi.org/10.1093/cid/ciu444.
Andreoni F, Zurcher C, Tarnutzer A, Schilcher K, Neff A, Keller N, et al. Clindamycin affects group A Streptococcus Virulence factors and improves clinical outcome. J Infect Dis. 2017;215:269–77. https://doi.org/10.1093/infdis/jiw229.
Alabi A, Kazimoto T, Lebughe M, Vubil D, Phaku P, Mandomando I, et al. Management of superficial and deep-seated Staphylococcus aureus skin and soft tissue infections in sub-Saharan Africa: a post hoc analysis of the StaphNet cohort. Infection. 2018;46:395–404. https://doi.org/10.1007/s15010-018-1140-6.
Levett D, Bennett MH, Millar I. Adjunctive hyperbaric oxygen for necrotizing fasciitis. Cochrane Database Syst Rev. 2015. https://doi.org/10.1002/14651858.cd007937.pub2.
Madsen MB, Hjortrup PB, Hansen MB, Lange T, Norrby-Teglund A, Hyldegaard O, et al. Immunoglobulin G for patients with necrotising soft tissue infection (INSTINCT): a randomised, blinded, placebo-controlled trial. Intensive Care Med. 2017;43:1585–93. https://doi.org/10.1007/s00134-017-4786-0.
Hua C, Bosc R, Sbidian E, De Prost N, Hughes C, Jabre P, et al. Interventions for necrotizing soft tissue infections in adults. Cochrane Database Syst Rev. 2018. https://doi.org/10.1002/14651858.cd011680.pub2.
Author information
Authors and Affiliations
Corresponding author
Ethics declarations
Conflict of interest
In the last 3 years NJ has received lecture fees from Gilead, Infectopharm and MSD and travel grants from Gilead, Basilea and Correvio. CE received honoraria for lectures and as consultant from Angelini, Menarini, MSD, Nabriva and Pfizer and research and travel support by ECDC, WHO and Niedersächsisches Landesgesundheitsamt.
Rights and permissions
About this article
Cite this article
Jung, N., Eckmann, C. Essentials in the management of necrotizing soft-tissue infections. Infection 47, 677–679 (2019). https://doi.org/10.1007/s15010-019-01316-3
Received:
Accepted:
Published:
Issue Date:
DOI: https://doi.org/10.1007/s15010-019-01316-3